2014
DOI: 10.1002/ejhf.49
|View full text |Cite
|
Sign up to set email alerts
|

Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation

Abstract: AimsSoluble urokinase plasminogen activator receptor (suPAR) in plasma is a novel inflammatory marker thought to be released from the cell surface of neutrophils, T cells, and macrophages. Other inflammatory markers, mainly acute phase proteins produced in the liver, have been associated with the incidence of heart failure (HF) and atrial fibrillation (AF). We investigated the association between suPAR and incident HF and AF in a population-based cohort. Methods and resultsSoluble urokinase plasminogen activa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

5
36
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 52 publications
(44 citation statements)
references
References 48 publications
5
36
0
1
Order By: Relevance
“…In the last decade, circulating biomarkers, such as N-terminal pro brain natriuretic peptide (NT-proBNP), have been studied for prediction of incident HF [7][8][9][10] . A recently published study 10 , also investigated the association of multiple proteins with incident HF for "prediction" purposes; these proteins (n=80) added little gain to the prognostic model including natriuretic peptides.…”
Section: Introductionmentioning
confidence: 99%
“…In the last decade, circulating biomarkers, such as N-terminal pro brain natriuretic peptide (NT-proBNP), have been studied for prediction of incident HF [7][8][9][10] . A recently published study 10 , also investigated the association of multiple proteins with incident HF for "prediction" purposes; these proteins (n=80) added little gain to the prognostic model including natriuretic peptides.…”
Section: Introductionmentioning
confidence: 99%
“…Elevated plasma levels of suPAR have been associated with coronary calcification,2 systemic inflammation3 and heart failure 4…”
Section: Introductionmentioning
confidence: 99%
“…The discovery of new biomarkers for heart failure could not only improve the assessment of heart failure risk, but also provide insights into the underlying pathophysiology. In the last decade, a few circulating biomarkers, such as growth differentiation factor 15 (GDF‐15), and urokinase‐type plasminogen activator surface receptor (U‐PAR) have been suggested as predictors of incident heart failure, but have generally only provided a modest improvement in risk prediction beyond established cardiovascular risk factors and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) …”
Section: Introductionmentioning
confidence: 99%